Netilmicin Use in Pediatric Patients
- 1 January 1980
- journal article
- research article
- Published by S. Karger AG in Developmental Pharmacology and Therapeutics
- Vol. 1 (4) , 238-253
- https://doi.org/10.1159/000455541
Abstract
40 newborn infants and children were treatcd with netilmicin. With a 2-mg/kg dose, the average peak serum concentration was 4.4 μg/ml. Serum concentrations resulting from the first dose were markedly lower than subsequent doses and therapeutically inadequate. Significant drug accumulation did not occur: peak and trough concentrations on days 2 and 7 were the same in patients with normal renal function. The half-life of netilmicin in infants Jess than I weck old was 3. 8 h, and 3. 0 h in infants older than I weck. Infants Jess than 7 days old require a prolonged dose interval (12 h ) to adequately clear the administered dose. Recovery of netilmicin in urine ranged from 50 to 100% and correlated with age and duration of treatment. Elimination of netilmicin was prolonged in newborn infants with renal failure and requires dosage adjustment. Transient change in creatinine clearance occurred in 2 patients (4.6%,) and ototoxicity was observed in 2 other patients.This publication has 6 references indexed in Scilit:
- Pharmacokinetic Properties of Netilmicin in Newborn InfantsAntimicrobial Agents and Chemotherapy, 1979
- Use of gentamicin serum levels to individualize therapy in childrenThe Journal of Pediatrics, 1978
- Pharmacology and Efficacy of NetilmicinAntimicrobial Agents and Chemotherapy, 1978
- Netilmicin: Clinical Efficacy, Tolerance, and ToxicityAntimicrobial Agents and Chemotherapy, 1978
- EVALUATION OF 3 ANTIBIOTIC PROGRAMS IN NEWBORN-INFANTS1978
- Activity of netilmicin against selected strains of Gram-negative bacteria and Staphylococcus aureus: comparison with four other aminoglycosidesJournal of Antimicrobial Chemotherapy, 1977